143 related articles for article (PubMed ID: 2210980)
21. The use of salivary stimulant pastilles to improve compliance in women taking oxybutynin hydrochloride for detrusor instability: a pilot study.
Hooper P; Tincello DG; Richmond DH
Br J Urol; 1997 Sep; 80(3):414-6. PubMed ID: 9313659
[TBL] [Abstract][Full Text] [Related]
22. [Topical treatment with oxybutynin chloride in neurogenic incontinence].
López Pereira P; Martínez MJ; Muguerza R; Jaureguizar E
Cir Pediatr; 1993 Jan; 6(1):29-31. PubMed ID: 8499234
[TBL] [Abstract][Full Text] [Related]
23. Follow-up of long-time treatment with intravesical oxybutynin for neurogenic bladder in children.
Amark P; Bussman G; Eksborg S
Eur Urol; 1998 Aug; 34(2):148-53. PubMed ID: 9693251
[TBL] [Abstract][Full Text] [Related]
24. Intravesical oxybutynin chloride: experience with 42 patients.
Weese DL; Roskamp DA; Leach GE; Zimmern PE
Urology; 1993 Jun; 41(6):527-30. PubMed ID: 8516987
[TBL] [Abstract][Full Text] [Related]
25. Clinical reevaluation of the effect of oxybutynin chloride on uninhibited neurogenic and reflex neurogenic bladder.
Kawabe K; Abe S; Kanda T; Tei K
Urol Int; 1986; 41(1):16-20. PubMed ID: 3962017
[TBL] [Abstract][Full Text] [Related]
26. Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability.
Halaska M; Ralph G; Wiedemann A; Primus G; Ballering-Brühl B; Höfner K; Jonas U
World J Urol; 2003 May; 20(6):392-9. PubMed ID: 12811500
[TBL] [Abstract][Full Text] [Related]
27. The use of intravesical oxybutynin chloride in patients with detrusor hypertonicity and detrusor hyperreflexia.
Kasabian NG; Vlachiotis JD; Lais A; Klumpp B; Kelly MD; Siroky MB; Bauer SB
J Urol; 1994 Apr; 151(4):944-5. PubMed ID: 8126833
[TBL] [Abstract][Full Text] [Related]
28. Oxybutynin versus propantheline in patients with multiple sclerosis and detrusor hyperreflexia.
Gajewski JB; Awad SA
J Urol; 1986 May; 135(5):966-8. PubMed ID: 3959249
[TBL] [Abstract][Full Text] [Related]
29. [Topical use of oxybutynin hydrochloride in women with urge incontinence].
Enzelsberger H; Kurz C; Helmer H
Gynakol Geburtshilfliche Rundsch; 1994; 34(1):23-4. PubMed ID: 8019165
[TBL] [Abstract][Full Text] [Related]
30. Long-term changes in urodynamic studies of voiding in the elderly.
Griffiths D; Harrison G; Moore K; McCracken P
Urol Res; 1994; 22(4):235-8. PubMed ID: 7871636
[TBL] [Abstract][Full Text] [Related]
31. Treatment of detrusor instability with oxybutynin rectal suppositories.
Winkler HA; Sand PK
Int Urogynecol J Pelvic Floor Dysfunct; 1998; 9(2):100-2. PubMed ID: 9694139
[TBL] [Abstract][Full Text] [Related]
32. Urodynamic verification of an overactive bladder is not a prerequisite for antimuscarinic treatment response.
Malone-Lee J; Henshaw DJ; Cummings K
BJU Int; 2003 Sep; 92(4):415-7. PubMed ID: 12930431
[TBL] [Abstract][Full Text] [Related]
33. The use of intravesical oxybutynin chloride in children with neurogenic bladder.
Greenfield SP; Fera M
J Urol; 1991 Aug; 146(2 ( Pt 2)):532-4. PubMed ID: 1861294
[TBL] [Abstract][Full Text] [Related]
34. Clinical efficacy of oxybutynin on sensory urgency as compared with that on motor urgency.
Hashimoto K; Ohnishi N; Esa A; Sugiyama T; Park Y; Kurita T
Urol Int; 1999; 62(1):12-6. PubMed ID: 10436424
[TBL] [Abstract][Full Text] [Related]
35. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
Goldenberg MM
Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730
[TBL] [Abstract][Full Text] [Related]
36. Comparison of urodynamic findings and response to oxybutynin in nocturnal enuresis.
Persson-Jünemann C; Seemann O; Köhrmann KU; Jünemann KP; Alken P
Eur Urol; 1993; 24(1):92-6. PubMed ID: 8365449
[TBL] [Abstract][Full Text] [Related]
37. [Effect of oxybutynin on lower urinary tract function].
Nishizawa O; Sugaya K; Suzuki T; Kohama T; Matsuzaki A; Fukuda T; Harada T; Tsuchida S
Hinyokika Kiyo; 1988 Aug; 34(8):1383-7. PubMed ID: 3195406
[TBL] [Abstract][Full Text] [Related]
38. Tethered cord syndrome in an adult. Pharmacological treatment of the urological symptomatology by oxybutynin.
De Angelis M; Martina G; Caverni L; Coglitore A; Libanori GP; Giannotti P
Acta Urol Belg; 1986; 54(1):99-105. PubMed ID: 3962800
[No Abstract] [Full Text] [Related]
39. Trospium chloride versus oxybutynin: a randomized, double-blind, multicentre trial in the treatment of detrusor hyper-reflexia.
Madersbacher H; Stöhrer M; Richter R; Burgdörfer H; Hachen HJ; Mürtz G
Br J Urol; 1995 Apr; 75(4):452-6. PubMed ID: 7788255
[TBL] [Abstract][Full Text] [Related]
40. Oxybutynin with bladder retraining for detrusor instability in elderly people: a randomized controlled trial.
Szonyi G; Collas DM; Ding YY; Malone-Lee JG
Age Ageing; 1995 Jul; 24(4):287-91. PubMed ID: 7484484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
